Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

Correction to: Whole exome sequencing in familial isolated primary hyperparathyroidism.

Cetani F, Pardi E, Aretini P, Saponaro F, Borsari S, Mazoni L, Apicella M, Civita P, La Ferla M, Caligo MA, Lessi F, Mazzanti CM, Torregrossa L, Oppo A, Marcocci C.

J Endocrinol Invest. 2020 Mar;43(3):399. doi: 10.1007/s40618-019-01118-2.

PMID:
31559585
2.

Mouse mammary tumor virus (MMTV) - like exogenous sequences are associated with sporadic but not hereditary human breast carcinoma.

Naccarato AG, Lessi F, Zavaglia K, Scatena C, Al Hamad MA, Aretini P, Menicagli M, Roncella M, Ghilli M, Caligo MA, Mazzanti CM, Bevilacqua G.

Aging (Albany NY). 2019 Sep 13;11(17):7236-7241. doi: 10.18632/aging.102252. Epub 2019 Sep 13.

3.

Germline investigation in male breast cancer of DNA repair genes by next-generation sequencing.

Scarpitta R, Zanna I, Aretini P, Gambino G, Scatena C, Mei B, Ghilli M, Rossetti E, Roncella M, Congregati C, Bonci F, Naccarato AG, Palli D, Caligo MA.

Breast Cancer Res Treat. 2019 Dec;178(3):557-564. doi: 10.1007/s10549-019-05429-z. Epub 2019 Sep 11.

PMID:
31512090
4.

Whole exome sequencing in familial isolated primary hyperparathyroidism.

Cetani F, Pardi E, Aretini P, Saponaro F, Borsari S, Mazoni L, Apicella M, Civita P, La Ferla M, Caligo MA, Lessi F, Mazzanti CM, Torregossa L, Oppo A, Marcocci C.

J Endocrinol Invest. 2020 Feb;43(2):231-245. doi: 10.1007/s40618-019-01107-5. Epub 2019 Sep 5. Erratum in: J Endocrinol Invest. 2019 Sep 26;:.

PMID:
31486992
5.

ANKRD44 Gene Silencing: A Putative Role in Trastuzumab Resistance in Her2-Like Breast Cancer.

La Ferla M, Lessi F, Aretini P, Pellegrini D, Franceschi S, Tantillo E, Menicagli M, Marchetti I, Scopelliti C, Civita P, De Angelis C, Diodati L, Bertolini I, Roncella M, McDonnell LA, Hochman J, Del Re M, Scatena C, Naccarato AG, Fontana A, Mazzanti CM.

Front Oncol. 2019 Jun 26;9:547. doi: 10.3389/fonc.2019.00547. eCollection 2019. Erratum in: Front Oncol. 2019 Jul 18;9:709.

6.

Laser Capture Microdissection and RNA-Seq Analysis: High Sensitivity Approaches to Explain Histopathological Heterogeneity in Human Glioblastoma FFPE Archived Tissues.

Civita P, Franceschi S, Aretini P, Ortenzi V, Menicagli M, Lessi F, Pasqualetti F, Naccarato AG, Mazzanti CM.

Front Oncol. 2019 Jun 7;9:482. doi: 10.3389/fonc.2019.00482. eCollection 2019.

7.

Rescuing cones and daylight vision in retinitis pigmentosa mice.

Guadagni V, Biagioni M, Novelli E, Aretini P, Mazzanti CM, Strettoi E.

FASEB J. 2019 Sep;33(9):10177-10192. doi: 10.1096/fj.201900414R. Epub 2019 Jun 14.

8.

Molecular profiling of microinvasive breast cancer microenvironment progression.

Lessi F, Scatena C, Aretini P, Menicagli M, Franceschi S, Naccarato AG, Mazzanti CM.

J Transl Med. 2019 Jun 3;17(1):187. doi: 10.1186/s12967-019-1936-x.

9.

Overexpression of the cohesin-core subunit SMC1A contributes to colorectal cancer development.

Sarogni P, Palumbo O, Servadio A, Astigiano S, D'Alessio B, Gatti V, Cukrov D, Baldari S, Pallotta MM, Aretini P, Dell'Orletta F, Soddu S, Carella M, Toietta G, Barbieri O, Fontanini G, Musio A.

J Exp Clin Cancer Res. 2019 Mar 1;38(1):108. doi: 10.1186/s13046-019-1116-0.

10.

Molecular characterization of low grade and high grade bladder cancer.

Apollo A, Ortenzi V, Scatena C, Zavaglia K, Aretini P, Lessi F, Franceschi S, Tomei S, Sepich CA, Viacava P, Mazzanti CM, Naccarato AG.

PLoS One. 2019 Jan 16;14(1):e0210635. doi: 10.1371/journal.pone.0210635. eCollection 2019.

11.

Doxycycline, an Inhibitor of Mitochondrial Biogenesis, Effectively Reduces Cancer Stem Cells (CSCs) in Early Breast Cancer Patients: A Clinical Pilot Study.

Scatena C, Roncella M, Di Paolo A, Aretini P, Menicagli M, Fanelli G, Marini C, Mazzanti CM, Ghilli M, Sotgia F, Lisanti MP, Naccarato AG.

Front Oncol. 2018 Oct 12;8:452. doi: 10.3389/fonc.2018.00452. eCollection 2018.

12.

Mitochondrial enzyme GLUD2 plays a critical role in glioblastoma progression.

Franceschi S, Corsinovi D, Lessi F, Tantillo E, Aretini P, Menicagli M, Scopelliti C, Civita P, Pasqualetti F, Naccarato AG, Ori M, Mazzanti CM.

EBioMedicine. 2018 Nov;37:56-67. doi: 10.1016/j.ebiom.2018.10.008. Epub 2018 Oct 9.

13.

Serotonin depletion causes valproate-responsive manic-like condition and increased hippocampal neuroplasticity that are reversed by stress.

Maddaloni G, Migliarini S, Napolitano F, Giorgi A, Nazzi S, Biasci D, De Felice A, Gritti M, Cavaccini A, Galbusera A, Franceschi S, Lessi F, Ferla M, Aretini P, Mazzanti CM, Tonini R, Gozzi A, Usiello A, Pasqualetti M.

Sci Rep. 2018 Aug 7;8(1):11847. doi: 10.1038/s41598-018-30291-2.

14.

Next generation sequencing technologies for a successful diagnosis in a cold case of Leigh syndrome.

Aretini P, Mazzanti CM, La Ferla M, Franceschi S, Lessi F, De Gregorio V, Nesti C, Valetto A, Bertini V, Toschi B, Battini R, Caligo MA.

BMC Neurol. 2018 Jul 20;18(1):99. doi: 10.1186/s12883-018-1103-7.

15.

Cancer astrocytes have a more conserved molecular status in long recurrence free survival (RFS) IDH1 wild-type glioblastoma patients: new emerging cancer players.

Franceschi S, Lessi F, Aretini P, Ortenzi V, Scatena C, Menicagli M, La Ferla M, Civita P, Zavaglia K, Scopelliti C, Apollo A, Carbone FG, Vannozzi R, Bevilacqua G, Pasqualetti F, Naccarato AG, Mazzanti CM.

Oncotarget. 2018 May 8;9(35):24014-24027. doi: 10.18632/oncotarget.25265. eCollection 2018 May 8.

16.

Whole-exome analysis in osteosarcoma to identify a personalized therapy.

Chiappetta C, Mancini M, Lessi F, Aretini P, De Gregorio V, Puggioni C, Carletti R, Petrozza V, Civita P, Franceschi S, Naccarato AG, Rocca CD, Mazzanti CM, Di Cristofano C.

Oncotarget. 2017 Jul 5;8(46):80416-80428. doi: 10.18632/oncotarget.19010. eCollection 2017 Oct 6.

17.

Whole-exome analysis of a Li-Fraumeni family trio with a novel TP53 PRD mutation and anticipation profile.

Franceschi S, Spugnesi L, Aretini P, Lessi F, Scarpitta R, Galli A, Congregati C, Caligo MA, Mazzanti CM.

Carcinogenesis. 2017 Sep 1;38(9):938-943. doi: 10.1093/carcin/bgx069.

PMID:
28911001
18.

CXCL12α/SDF-1 from perisynaptic Schwann cells promotes regeneration of injured motor axon terminals.

Negro S, Lessi F, Duregotti E, Aretini P, La Ferla M, Franceschi S, Menicagli M, Bergamin E, Radice E, Thelen M, Megighian A, Pirazzini M, Mazzanti CM, Rigoni M, Montecucco C.

EMBO Mol Med. 2017 Aug;9(8):1000-1010. doi: 10.15252/emmm.201607257.

19.

Loss of c-KIT expression in thyroid cancer cells.

Franceschi S, Lessi F, Panebianco F, Tantillo E, La Ferla M, Menicagli M, Aretini P, Apollo A, Naccarato AG, Marchetti I, Mazzanti CM.

PLoS One. 2017 Mar 16;12(3):e0173913. doi: 10.1371/journal.pone.0173913. eCollection 2017.

20.

Germline mutations in DNA repair genes may predict neoadjuvant therapy response in triple negative breast patients.

Spugnesi L, Gabriele M, Scarpitta R, Tancredi M, Maresca L, Gambino G, Collavoli A, Aretini P, Bertolini I, Salvadori B, Landucci E, Fontana A, Rossetti E, Roncella M, Naccarato GA, Caligo MA.

Genes Chromosomes Cancer. 2016 Dec;55(12):915-924. doi: 10.1002/gcc.22389. Epub 2016 Jul 26.

PMID:
27328445
21.

Molecular portrait of a rare case of metastatic glioblastoma: somatic and germline mutations using whole-exome sequencing.

Franceschi S, Lessi F, Aretini P, Mazzanti CM, Menicagli M, La Ferla M, De Gregorio V, Caramella D, Naccarato AG, Bevilacqua G, Bonadio AG, Pasqualetti F.

Neuro Oncol. 2016 Feb;18(2):298-300. doi: 10.1093/neuonc/nov314. No abstract available.

22.

Investigating molecular alterations to profile short- and long-term recurrence-free survival in patients with primary glioblastoma.

Franceschi S, Mazzanti CM, Lessi F, Aretini P, Carbone FG, LA Ferla M, Scatena C, Ortenzi V, Vannozzi R, Fanelli G, Pasqualetti F, Bevilacqua G, Zavaglia K, Naccarato AG.

Oncol Lett. 2015 Dec;10(6):3599-3606. Epub 2015 Sep 23.

23.

The combination of four molecular markers improves thyroid cancer cytologic diagnosis and patient management.

Panebianco F, Mazzanti C, Tomei S, Aretini P, Franceschi S, Lessi F, Di Coscio G, Bevilacqua G, Marchetti I.

BMC Cancer. 2015 Nov 19;15:918. doi: 10.1186/s12885-015-1917-2.

24.

Association between RAD 51 rs1801320 and susceptibility to glioblastoma.

Franceschi S, Tomei S, Mazzanti CM, Lessi F, Aretini P, La Ferla M, De Gregorio V, Pasqualetti F, Zavaglia K, Bevilacqua G, Naccarato AG.

J Neurooncol. 2016 Jan;126(2):265-70. doi: 10.1007/s11060-015-1974-z. Epub 2015 Oct 28.

PMID:
26511493
25.

MSH2 role in BRCA1-driven tumorigenesis: A preliminary study in yeast and in human tumors from BRCA1-VUS carriers.

Maresca L, Spugnesi L, Lodovichi S, Cozzani C, Naccarato AG, Tancredi M, Collavoli A, Falaschi E, Rossetti E, Aretini P, Cervelli T, Galli A, Caligo MA.

Eur J Med Genet. 2015 Oct;58(10):531-9. doi: 10.1016/j.ejmg.2015.09.005. Epub 2015 Sep 14.

PMID:
26381082
26.

Human saliva as route of inter-human infection for mouse mammary tumor virus.

Mazzanti CM, Lessi F, Armogida I, Zavaglia K, Franceschi S, Al Hamad M, Roncella M, Ghilli M, Boldrini A, Aretini P, Fanelli G, Marchetti I, Scatena C, Hochman J, Naccarato AG, Bevilacqua G.

Oncotarget. 2015 Jul 30;6(21):18355-63.

27.

BRCA1 gene variant p.P142H associated with male breast cancer: a two-generation genealogic study and literature review.

Spinelli C, Strambi S, Piccini L, Rossi L, Aretini P, Caligo A.

Fam Cancer. 2015 Dec;14(4):515-9. doi: 10.1007/s10689-015-9819-7. Review.

PMID:
26085381
28.

Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer.

Rebbeck TR, Mitra N, Wan F, Sinilnikova OM, Healey S, McGuffog L, Mazoyer S, Chenevix-Trench G, Easton DF, Antoniou AC, Nathanson KL; CIMBA Consortium, Laitman Y, Kushnir A, Paluch-Shimon S, Berger R, Zidan J, Friedman E, Ehrencrona H, Stenmark-Askmalm M, Einbeigi Z, Loman N, Harbst K, Rantala J, Melin B, Huo D, Olopade OI, Seldon J, Ganz PA, Nussbaum RL, Chan SB, Odunsi K, Gayther SA, Domchek SM, Arun BK, Lu KH, Mitchell G, Karlan BY, Walsh C, Lester J, Godwin AK, Pathak H, Ross E, Daly MB, Whittemore AS, John EM, Miron A, Terry MB, Chung WK, Goldgar DE, Buys SS, Janavicius R, Tihomirova L, Tung N, Dorfling CM, van Rensburg EJ, Steele L, Neuhausen SL, Ding YC, Ejlertsen B, Gerdes AM, Hansen Tv, Ramón y Cajal T, Osorio A, Benitez J, Godino J, Tejada MI, Duran M, Weitzel JN, Bobolis KA, Sand SR, Fontaine A, Savarese A, Pasini B, Peissel B, Bonanni B, Zaffaroni D, Vignolo-Lutati F, Scuvera G, Giannini G, Bernard L, Genuardi M, Radice P, Dolcetti R, Manoukian S, Pensotti V, Gismondi V, Yannoukakos D, Fostira F, Garber J, Torres D, Rashid MU, Hamann U, Peock S, Frost D, Platte R, Evans DG, Eeles R, Davidson R, Eccles D, Cole T, Cook J, Brewer C, Hodgson S, Morrison PJ, Walker L, Porteous ME, Kennedy MJ, Izatt L, Adlard J, Donaldson A, Ellis S, Sharma P, Schmutzler RK, Wappenschmidt B, Becker A, Rhiem K, Hahnen E, Engel C, Meindl A, Engert S, Ditsch N, Arnold N, Plendl HJ, Mundhenke C, Niederacher D, Fleisch M, Sutter C, Bartram CR, Dikow N, Wang-Gohrke S, Gadzicki D, Steinemann D, Kast K, Beer M, Varon-Mateeva R, Gehrig A, Weber BH, Stoppa-Lyonnet D, Sinilnikova OM, Mazoyer S, Houdayer C, Belotti M, Gauthier-Villars M, Damiola F, Boutry-Kryza N, Lasset C, Sobol H, Peyrat JP, Muller D, Fricker JP, Collonge-Rame MA, Mortemousque I, Nogues C, Rouleau E, Isaacs C, De Paepe A, Poppe B, Claes K, De Leeneer K, Piedmonte M, Rodriguez G, Wakely K, Boggess J, Blank SV, Basil J, Azodi M, Phillips KA, Caldes T, de la Hoya M, Romero A, Nevanlinna H, Aittomäki K, van der Hout AH, Hogervorst FB, Verhoef S, Collée JM, Seynaeve C, Oosterwijk JC, Gille JJ, Wijnen JT, Gómez Garcia EB, Kets CM, Ausems MG, Aalfs CM, Devilee P, Mensenkamp AR, Kwong A, Olah E, Papp J, Diez O, Lazaro C, Darder E, Blanco I, Salinas M, Jakubowska A, Lubinski J, Gronwald J, Jaworska-Bieniek K, Durda K, Sukiennicki G, Huzarski T, Byrski T, Cybulski C, Toloczko-Grabarek A, Złowocka-Perłowska E, Menkiszak J, Arason A, Barkardottir RB, Simard J, Laframboise R, Montagna M, Agata S, Alducci E, Peixoto A, Teixeira MR, Spurdle AB, Lee MH, Park SK, Kim SW, Friebel TM, Couch FJ, Lindor NM, Pankratz VS, Guidugli L, Wang X, Tischkowitz M, Foretova L, Vijai J, Offit K, Robson M, Rau-Murthy R, Kauff N, Fink-Retter A, Singer CF, Rappaport C, Gschwantler-Kaulich D, Pfeiler G, Tea MK, Berger A, Greene MH, Mai PL, Imyanitov EN, Toland AE, Senter L, Bojesen A, Pedersen IS, Skytte AB, Sunde L, Thomassen M, Moeller ST, Kruse TA, Jensen UB, Caligo MA, Aretini P, Teo SH, Selkirk CG, Hulick PJ, Andrulis I.

JAMA. 2015 Apr 7;313(13):1347-61. doi: 10.1001/jama.2014.5985. Erratum in: JAMA. 2015 Aug 11;314(6):628.

29.

Characterization of three alternative transcripts of the BRCA1 gene in patients with breast cancer and a family history of breast and/or ovarian cancer who tested negative for pathogenic mutations.

Gambino G, Tancredi M, Falaschi E, Aretini P, Caligo MA.

Int J Mol Med. 2015 Apr;35(4):950-6. doi: 10.3892/ijmm.2015.2103. Epub 2015 Feb 16.

30.

Identification of two novel BRCA1-partner genes in the DNA double-strand break repair pathway.

Guglielmi C, Cerri I, Evangelista M, Collavoli A, Tancredi M, Aretini P, Caligo MA.

Breast Cancer Res Treat. 2013 Oct;141(3):515-22. doi: 10.1007/s10549-013-2705-9. Epub 2013 Oct 9.

PMID:
24104880
31.

A molecular computational model improves the preoperative diagnosis of thyroid nodules.

Tomei S, Marchetti I, Zavaglia K, Lessi F, Apollo A, Aretini P, Di Coscio G, Bevilacqua G, Mazzanti C.

BMC Cancer. 2012 Sep 7;12:396. doi: 10.1186/1471-2407-12-396.

32.

Association of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study.

Jakubowska A, Rozkrut D, Antoniou A, Hamann U, Scott RJ, McGuffog L, Healy S, Sinilnikova OM, Rennert G, Lejbkowicz F, Flugelman A, Andrulis IL, Glendon G, Ozcelik H; OCGN, Thomassen M, Paligo M, Aretini P; SWE-BRCA, Kantala J, Aroer B, von Wachenfeldt A, Liljegren A, Loman N, Herbst K, Kristoffersson U, Rosenquist R, Karlsson P, Stenmark-Askmalm M, Melin B, Nathanson KL, Domchek SM, Byrski T, Huzarski T, Gronwald J, Menkiszak J, Cybulski C, Serrano P, Osorio A, Cajal TR, Tsitlaidou M, Benítez J, Gilbert M; HEBON, Rookus M, Aalfs CM, Kluijt I, Boessenkool-Pape JL, Meijers-Heijboer HE, Oosterwijk JC, van Asperen CJ, Blok MJ, Nelen MR, van den Ouweland AM, Seynaeve C, van der Luijt RB, Devilee P; EMBRACE, Easton DF, Peock S, Frost D, Platte R, Ellis SD, Fineberg E, Evans DG, Lalloo F, Eeles R, Jacobs C, Adlard J, Davidson R, Eccles D, Cole T, Cook J, Godwin A, Bove B; GEMO Study Collaborators, Stoppa-Lyonnet D, Caux-Moncoutier V, Belotti M, Tirapo C, Mazoyer S, Barjhoux L, Boutry-Kryza N, Pujol P, Coupier I, Peyrat JP, Vennin P, Muller D, Fricker JP, Venat-Bouvet L, Johannsson OT, Isaacs C, Schmutzler R, Wappenschmidt B, Meindl A, Arnold N, Varon-Mateeva R, Niederacher D, Sutter C, Deissler H, Preisler-Adams S, Simard J, Soucy P, Durocher F, Chenevix-Trench G, Beesley J, Chen X; KConFab, Rebbeck T, Couch F, Wang X, Lindor N, Fredericksen Z, Pankratz VS, Peterlongo P, Bonanni B, Fortuzzi S, Peissel B, Szabo C, Mai PL, Loud JT, Lubinski J; CIMBA, the Consortium of Investigators of Modifiers of BRCA1/2-Related Cancer.

Br J Cancer. 2012 Jun 5;106(12):2016-24. doi: 10.1038/bjc.2012.160. Epub 2012 May 15.

33.

BRCA1 and BRCA2 germline mutations in Moroccan breast/ovarian cancer families: novel mutations and unclassified variants.

Tazzite A, Jouhadi H, Nadifi S, Aretini P, Falaschi E, Collavoli A, Benider A, Caligo MA.

Gynecol Oncol. 2012 Jun;125(3):687-92. doi: 10.1016/j.ygyno.2012.03.007. Epub 2012 Mar 13.

PMID:
22425665
34.

c-KIT receptor expression is strictly associated with the biological behaviour of thyroid nodules.

Tomei S, Mazzanti C, Marchetti I, Rossi L, Zavaglia K, Lessi F, Apollo A, Aretini P, Di Coscio G, Bevilacqua G.

J Transl Med. 2012 Jan 10;10:7. doi: 10.1186/1479-5876-10-7.

35.

Detection of the BRAF(V600E) mutation in fine needle aspiration cytology of thyroid papillary microcarcinoma cells selected by manual macrodissection: an easy tool to improve the preoperative diagnosis.

Marchetti I, Iervasi G, Mazzanti CM, Lessi F, Tomei S, Naccarato AG, Aretini P, Alberti B, Di Coscio G, Bevilacqua G.

Thyroid. 2012 Mar;22(3):292-8. doi: 10.1089/thy.2011.0107. Epub 2011 Dec 19.

PMID:
22181337
36.

Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).

Mavaddat N, Barrowdale D, Andrulis IL, Domchek SM, Eccles D, Nevanlinna H, Ramus SJ, Spurdle A, Robson M, Sherman M, Mulligan AM, Couch FJ, Engel C, McGuffog L, Healey S, Sinilnikova OM, Southey MC, Terry MB, Goldgar D, O'Malley F, John EM, Janavicius R, Tihomirova L, Hansen TV, Nielsen FC, Osorio A, Stavropoulou A, Benítez J, Manoukian S, Peissel B, Barile M, Volorio S, Pasini B, Dolcetti R, Putignano AL, Ottini L, Radice P, Hamann U, Rashid MU, Hogervorst FB, Kriege M, van der Luijt RB; HEBON, Peock S, Frost D, Evans DG, Brewer C, Walker L, Rogers MT, Side LE, Houghton C; EMBRACE, Weaver J, Godwin AK, Schmutzler RK, Wappenschmidt B, Meindl A, Kast K, Arnold N, Niederacher D, Sutter C, Deissler H, Gadzicki D, Preisler-Adams S, Varon-Mateeva R, Schönbuchner I, Gevensleben H, Stoppa-Lyonnet D, Belotti M, Barjhoux L; GEMO Study Collaborators, Isaacs C, Peshkin BN, Caldes T, de la Hoya M, Cañadas C, Heikkinen T, Heikkilä P, Aittomäki K, Blanco I, Lazaro C, Brunet J, Agnarsson BA, Arason A, Barkardottir RB, Dumont M, Simard J, Montagna M, Agata S, D'Andrea E, Yan M, Fox S; kConFab Investigators, Rebbeck TR, Rubinstein W, Tung N, Garber JE, Wang X, Fredericksen Z, Pankratz VS, Lindor NM, Szabo C, Offit K, Sakr R, Gaudet MM, Singer CF, Tea MK, Rappaport C, Mai PL, Greene MH, Sokolenko A, Imyanitov E, Toland AE, Senter L, Sweet K, Thomassen M, Gerdes AM, Kruse T, Caligo M, Aretini P, Rantala J, von Wachenfeld A, Henriksson K; SWE-BRCA Collaborators, Steele L, Neuhausen SL, Nussbaum R, Beattie M, Odunsi K, Sucheston L, Gayther SA, Nathanson K, Gross J, Walsh C, Karlan B, Chenevix-Trench G, Easton DF, Antoniou AC; Consortium of Investigators of Modifiers of BRCA1/2.

Cancer Epidemiol Biomarkers Prev. 2012 Jan;21(1):134-47. doi: 10.1158/1055-9965.EPI-11-0775. Epub 2011 Dec 5.

37.

KLF4 is a novel candidate tumor suppressor gene in pancreatic ductal carcinoma.

Zammarchi F, Morelli M, Menicagli M, Di Cristofano C, Zavaglia K, Paolucci A, Campani D, Aretini P, Boggi U, Mosca F, Cavazzana A, Cartegni L, Bevilacqua G, Mazzanti CM.

Am J Pathol. 2011 Jan;178(1):361-72. doi: 10.1016/j.ajpath.2010.11.021. Epub 2010 Dec 23.

38.

A recombination-based method to characterize human BRCA1 missense variants.

Guidugli L, Rugani C, Lombardi G, Aretini P, Galli A, Caligo MA.

Breast Cancer Res Treat. 2011 Jan;125(1):265-72. doi: 10.1007/s10549-010-1112-8. Epub 2010 Aug 25.

PMID:
20737206
39.

The BRCAPRO 5.0 model is a useful tool in genetic counseling and clinical management of male breast cancer cases.

Zanna I, Rizzolo P, Sera F, Falchetti M, Aretini P, Giannini G, Masala G, Gulino A, Palli D, Ottini L.

Eur J Hum Genet. 2010 Jul;18(7):856-8. doi: 10.1038/ejhg.2010.29. Epub 2010 Mar 17.

40.

PIK3CA in breast carcinoma: a mutational analysis of sporadic and hereditary cases.

Michelucci A, Di Cristofano C, Lami A, Collecchi P, Caligo A, Decarli N, Leopizzi M, Aretini P, Bertacca G, Porta RP, Ricci S, Della Rocca C, Stanta G, Bevilacqua G, Cavazzana A.

Diagn Mol Pathol. 2009 Dec;18(4):200-5. doi: 10.1097/PDM.0b013e31818e5fa4.

PMID:
19861897
41.

A yeast recombination assay to characterize human BRCA1 missense variants of unknown pathological significance.

Caligo MA, Bonatti F, Guidugli L, Aretini P, Galli A.

Hum Mutat. 2009 Jan;30(1):123-33. doi: 10.1002/humu.20817.

PMID:
18680205
42.

Evaluation of FISH image analysis system on assessing HER2 amplification in breast carcinoma cases.

Theodosiou Z, Kasampalidis IN, Karayannopoulou G, Kostopoulos I, Bobos M, Bevilacqua G, Aretini P, Starita A, Lyroudia K, Pitas I.

Breast. 2008 Feb;17(1):80-4. Epub 2007 Sep 21.

PMID:
17889539
43.

Identification of novel alternatively spliced BRCA1-associated RING domain (BARD1) messenger RNAs in human peripheral blood lymphocytes and in sporadic breast cancer tissues.

Lombardi G, Falaschi E, Di Cristofano C, Naccarato AG, Sensi E, Aretini P, Roncella M, Bevilacqua G, Caligo MA.

Genes Chromosomes Cancer. 2007 Sep;46(9):791-5.

PMID:
17497650
44.

Markers of cell proliferation, apoptosis, and angiogenesis in thyroid adenomas: a comparative immunohistochemical and genetic investigation of functioning and nonfunctioning nodules.

Viacava P, Bocci G, Tonacchera M, Fanelli G, DeServi M, Agretti P, Berti E, Goletti O, Aretini P, Resta ML, Bevilacqua G, Naccarato AG.

Thyroid. 2007 Mar;17(3):191-7.

PMID:
17381350
45.

High level of messenger RNA for BRMS1 in primary breast carcinomas is associated with poor prognosis.

Lombardi G, Di Cristofano C, Capodanno A, Iorio MC, Aretini P, Isola P, Tancredi M, Collecchi P, Naccarato AG, Porta RP, Bevilacqua G, Caligo MA.

Int J Cancer. 2007 Mar 15;120(6):1169-78.

46.

Methyl group metabolism gene polymorphisms as modifier of breast cancer risk in Italian BRCA1/2 carriers.

Pepe C, Guidugli L, Sensi E, Aretini P, D'Andrea E, Montagna M, Manoukian S, Ottini L, Radice P, Viel A, Bevilacqua G, Caligo MA.

Breast Cancer Res Treat. 2007 May;103(1):29-36. Epub 2006 Dec 7.

PMID:
17151928
47.

HPV testing and Pap test: role for a combined approach in a non-screened population.

Marchetti I, Zavaglia K, Bertacca G, Aretini P, Matteoli B, Viacava P, Prato B, De Punzio C, Genazzani AR, Bevilacqua G, Di Coscio G.

Int J Biol Markers. 2006 Jul-Sep;21(3):149-56.

PMID:
17013796
48.

RNA-based analysis of BRCA1 and BRCA2 gene alterations.

Bonatti F, Pepe C, Tancredi M, Lombardi G, Aretini P, Sensi E, Falaschi E, Cipollini G, Bevilacqua G, Caligo MA.

Cancer Genet Cytogenet. 2006 Oct 15;170(2):93-101.

PMID:
17011978
49.

Papillary lesions of the breast: a molecular progression?

Di Cristofano C, Mrad K, Zavaglia K, Bertacca G, Aretini P, Cipollini G, Bevilacqua G, Ben Romdhane K, Cavazzana A.

Breast Cancer Res Treat. 2005 Mar;90(1):71-6.

PMID:
15770529
50.

Clinicopathological significance of GADD45 gene alterations in human familial breast carcinoma.

Sensi E, Tancredi M, Aretini P, Cipollini G, Collecchi P, Naccarato AG, Viacava P, Bevilacqua G, Caligo MA.

Breast Cancer Res Treat. 2004 Sep;87(2):197-201.

PMID:
15377844

Supplemental Content

Loading ...
Support Center